(Update with details on compensation, background)
March 10 (Reuters) - Australia's corporate watchdog said the country's six largest banking services providers have paid or offered A$4.7 billion ($3.10 billion) in compensation to customers who suffered losses for fees charged for services that were not provided.
The Australian Securities and Investments Commission (ASIC) said on Friday it undertook a review of the systems which led to wrongful fees being charged by the country's four biggest banks - Commonwealth Bank of Australia (CBA) , Westpac Banking (WBC) , ANZ Group (ANZ) and National Australia Bank (NAB) - plus investment bank Macquarie Group (MQG) and wealth manager AMP Ltd (AMP) .
The watchdog's order for customer compensation came at a time when each of the 'Big Four' - which account for the majority of lending in Australia - are being closely scrutinised for abusing their market dominance in the wake of scandals involving misleading financial advice, insurance fraud and interest-rate rigging.
The largest business lender in Australia, NAB, took the lead and coughed up A$1.49 billion in compensation as of the end of 2022, followed by CBA and Westpac coughing up a payout of A$1.13 billion and $1.03 billion, respectively.
ASIC said its final update on remediation figures "draws a line" under its eight-year long programme of addressing financial institutions' failure to provide ongoing services to fee-paying customers.
($1 = 1.5177 Australian dollars)
- Forums
- ASX - By Stock
- CBA
- News: CBA UPDATE 1-Australian regulator says banks paid $3.10 bln in compensation for wrongly...
CBA
commonwealth bank of australia.
Add to My Watchlist
2.81%
!
$185.36

News: CBA UPDATE 1-Australian regulator says banks paid $3.10 bln in compensation for wrongly...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$185.36 |
Change
-5.350(2.81%) |
Mkt cap ! $310.1B |
Open | High | Low | Value | Volume |
$190.50 | $191.06 | $185.36 | $367.6M | 1.971M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4521 | $185.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$185.88 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15 | 185.360 |
18 | 4516 | 185.000 |
1 | 50 | 184.950 |
4 | 383 | 184.500 |
1 | 15 | 184.400 |
Price($) | Vol. | No. |
---|---|---|
185.880 | 70 | 1 |
186.090 | 50 | 1 |
187.000 | 300 | 1 |
187.400 | 5 | 1 |
187.600 | 58 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
CBA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online